COVID-19 : All Pages

• COVID-19 Vaccine Trials
• Copyright
• Accessibility Statement
• About
• Contact Us
• Press Updates
• Ongoing studies
• Sponsors and Partners
• picture-credits
• Press Release Trial Open
• Blog: How long will it take to get the Oxford vaccine to deployment?
• Sign Up Closed
• Participate in a Trial - Southampton
• Participate in a trial - Oxford
• Participate in a trial - Imperial
• Participate in a trial - Bristol
• Statement following Government press briefing 21Apr20
• Phase I trial explained
• An interview with Sarah Gilbert
• Participate in a trial - St George's
• Potential international site - Kenya
• News about trial progress
• Participate-in-a-trial
• Participate-Oxford-2
• Participate Southampton
• Participate Newcastle
• Participate Birmingham
• Participate Nottingham
• Participate London
• Participate Guys & St Thomas'
• Participate Bristol
• Participate Sheffield
• Participate Glasgow
• Participate Aneurin Bevan
• Participate Edinburgh
• Participate Hull
• Participate St George's
• Participate Liverpool
• Participate UCLH
• Phase II/III Trial Explained
• Participate Imperial
• Participate Northwick Park
• Participate Cambridge
• UN Talk – Professor Sarah Gilbert
• Oxford Trial Site Brazil
• Brazil Trial launch
• Phase I Trial Publication
• Review of safety data
• Trial Resumes
• Brazilian trial resumes
• Oxford COVID-19 trial vaccinations resume in South Africa
• Phase II trial publication
• Breakthrough on global COVID-19 vaccine
• Interim Efficacy Results
• Regulatory approval
• Swabs
• Childrens Trial
• cov006-oxford
• cov006-st-georges
• cov006-bristol
• cov006-southampton
• childrens trial list
• FAQs Children's Trial
• Vaccine Certification for International Travel
• Outputs & Publications
• 2 billion doses
• Oxford Mosaic Accessibility Statement
• COVID-19: Use of cookies on this website